Repligen | 资产

金融业

USD

USD 2.95B

现金及等价物

USD 566.02M

USD 94.08M

USD 1.14B

USD 135.83M

USD 542.21M

USD 19.97M

USD 39.54M

1.78K

EPS每股收益

USD 0.49

股本和储备

USD 2.11B

USD 103.83M

债务利息支出

USD 5.5M

USD 7.31M

USD 542.21M

USD 6.97B

USD 13.29M

USD 177.95M

USD 19.97M

普通股股本

USD 56.33M

USD 164.06

USD 17.11M

USD 197.91M

销售和管理费用

USD 74.36M

USD 170.46M

贸易债权人

USD 30.01M

应收帐款人

USD 158.59M

	资产	更改		日
Agilent	USD 12.81B		86M	2025-12
Align Technology	USD 6.23B		141K	2025-12
Bio Techne	USD 2.52B		3.45M	2025-12
BioMarin Pharmaceutical	USD 7.59B		20.85M	2025-12
Bristol-Myers Squibb	USD 96.89B		2.21B	2025-09
Bruker	USD 6.24B		193.5M	2025-12
Charles River Laboratories	USD 7.14B		378.39M	2025-12
Danaher	USD 83.46B		3.57B	2025-12
Dentsply International	USD 5.43B		224M	2025-12
Exact Sciences	USD 5.86B		39.38M	2025-12
General Electric Aerospace	USD 130.17B		1.93B	2025-12
Henry Schein	USD 11.22B		118M	2025-12
Illumina	USD 6.64B		467M	2025-12
IQVIA Holdings	USD 29.94B		1.22B	2025-12
Mettler Toledo International	USD 3.71B		191.18M	2025-12
Myriad Genetics	USD 728.1M		50.8M	2025-09
OraSure Technologies	USD 423.1M		21.94M	2025-09
Pacific Biosciences Of California	USD 803.16M		22.31M	2025-09
Pfizer	USD 208.73B		2.64B	2025-09
Repligen	USD 2.95B		25.99M	2025-12
Revvity	USD 12.17B		29.46M	2025-12
Standard Biotools	USD 539.64M		17.32M	2025-09
Thermo Fisher Scientific	USD 110.34B		7.32B	2025-12
Waters	USD 5.08B		221.41M	2025-12
West Pharmaceutical Services	USD 4.27B		164.2M	2025-12

Repligen 资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.